LGND - Ligand acquires royalty on Sanofi's TZIELD for $20 million
2023-11-01 08:34:25 ET
More on Ligand Pharmaceuticals
- Ligand: Nothing Exciting Stands Out
- Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M
- Ligand Pharmaceuticals closes acquisition of assets of Novan
For further details see:
Ligand acquires royalty on Sanofi’s TZIELD for $20 million